Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance.

[1]  A. Hoes,et al.  Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. , 2000, Scandinavian journal of primary health care.

[2]  D. Grobbee,et al.  Pneumococcal vaccination of the elderly: do we need another trial? , 2000, Archives of internal medicine.

[3]  S. Manson,et al.  Influenza and pneumococcal vaccination among Native American elders in a primary care practice. , 2000, Archives of internal medicine.

[4]  W. Peetermans,et al.  Pneumococcal vaccination by general practitioners: an evaluation of current practice. , 1999, Vaccine.

[5]  J. Nguyen-Van-Tam,et al.  Family doctor advice is the main determinant of pneumococcal vaccine uptake. , 1999, Journal of epidemiology and community health.

[6]  R. Thompson,et al.  Safety of revaccination with pneumococcal polysaccharide vaccine. , 1999, JAMA.

[7]  K. Nichol.  Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. , 1998, The American journal of medicine.

[8]  W. Stalman,et al.  Improving influenza vaccination coverage among high-risk patients: a role for computer-supported prevention strategy? , 1998, Family practice.

[9]  J. Ayres,et al.  Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease , 1997, BMJ.

[10]  E. Friedman,et al.  Pneumococcal vaccine campaign based in general practice , 1997, BMJ.

[11]  K. Nichol,et al.  Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults , 1996, Journal of general internal medicine.

[12]  M. Fisch,et al.  Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. , 1995, Archives of internal medicine.

[13]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[14]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[15]  K. Sullivan,et al.  Predictors of vaccination behavior among persons ages 65 years and older. , 1990, American journal of public health.

[16]  Schwartz Js,et al.  The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly , 1988 .

[17]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[18]  E. Shapiro,et al.  A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. , 1984, Annals of internal medicine.

[19]  M. Hilleman,et al.  Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. , 1981, Reviews of infectious diseases.

[20]  C. Broome.  Efficacy of pneumococcal polysaccharide vaccines. , 1981, Reviews of infectious diseases.

[21]  M. Becker,et al.  Health Belief Model and Personal Health Behavior , 1976 .

[22]  I. Rosenstock.  The Health Belief Model and Preventive Health Behavior , 1974 .